Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue 1
Phase 2 study of pembrolizumab in patients with advanced rare cancers
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
This article has a correction. Please see:
Correction: Phase 2 study of pembrolizumab in patients with advanced rare cancers - April 01, 2020
PDF
XML
Clinical/translational cancer immunotherapy
Original research
Phase 2 study of pembrolizumab in patients with advanced rare cancers
Online download statistics by month:
Online download statistics by month: March 2020 to March 2024
Abstract
Full
Pdf
Mar 2020
1182
1182
321
Apr 2020
980
980
176
May 2020
334
334
98
Jun 2020
332
332
90
Jul 2020
285
287
68
Aug 2020
283
281
61
Sep 2020
347
347
68
Oct 2020
288
288
65
Nov 2020
332
333
73
Dec 2020
362
362
74
Jan 2021
525
525
107
Feb 2021
363
363
63
Mar 2021
507
507
94
Apr 2021
368
368
68
May 2021
244
244
62
Jun 2021
240
239
80
Jul 2021
302
302
80
Aug 2021
210
210
65
Sep 2021
401
401
80
Oct 2021
229
230
77
Nov 2021
460
462
94
Dec 2021
301
307
79
Jan 2022
347
368
106
Feb 2022
410
417
107
Mar 2022
253
260
71
Apr 2022
243
251
67
May 2022
216
222
69
Jun 2022
217
225
66
Jul 2022
187
197
68
Aug 2022
269
275
75
Sep 2022
151
155
63
Oct 2022
176
184
67
Nov 2022
218
219
49
Dec 2022
196
196
62
Jan 2023
187
187
45
Feb 2023
233
239
59
Mar 2023
199
201
57
Apr 2023
152
153
42
May 2023
152
152
31
Jun 2023
182
182
46
Jul 2023
165
169
55
Aug 2023
188
188
43
Sep 2023
134
137
45
Oct 2023
136
139
35
Nov 2023
138
138
52
Dec 2023
167
167
50
Jan 2024
124
127
53
Feb 2024
101
101
37
Mar 2024
159
165
128
Total
14175
14298
3691
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF